EFORM – 23AC-XBRL –Form for filing XBRL document in respect of balance sheet and other documents with the Registrar NOTE: ♦ This Form 23AC-XBRL is applicable in respect of the following companies: 1. All Listed companies.; 2. All companies which are subsidiaries of listed companies 3. All companies having a paid up capital of Rs. […]
Cisco Systems Capital (India) Private Limited Vs DCIT (ITAT Bangalore) The assessee grievance is bundled approach for benchmarking should be accepted. At the outset, the ld. AR submitted that the TPO has accepted the bundled approach of aggregation of payment of fees for administrative support services in the preceding years (i.e. from the incorporation year […]
The TPO and DRP erred in treating CCDs as ECBs and benchmarked the interest rate against LIBOR rate. The CCDs is a hybrid instrument and cannot be per se treated as ECB / loan.
It has been decided that in case of accredited investors, the limits and modes of fees payable to the IA shall be governed through bilaterally negotiated contractual terms and the provisions of para 2(iii) of the Circular shall not be applicable. The other provisions of the Circular shall remain unchanged.
AOC – 4 X BRL – Form for filing XBRL document in respect of financial statement and other documents with the Registrar Part I – Law(s) Governing the eForm eForm AOC-4 XBRL Pursuant to section 137 of the Companies Act, 2013 and rule 12(2) of the Companies (Accounts) Rules, 2014 read with Companies (Filing of documents […]
Part I – Law(s) Governing the eForm MGT-7 Pursuant to Section 92(1) of the Companies Act, 2013 and rule 11(1) of the Companies (Management and Administration) Rules, 2014. (Refer Annexure A) Purpose of the eForm MGT-7 Every company shall prepare an annual return in the form MGT-7 containing the particulars as they stood on the […]
eForm MR-2 – Form of application to the Central Government for approval of appointment or reappointment and remuneration or increase in remuneration or waiver for excess or over payment to managing director or whole time director or manager and commission or remuneration to directors. Part I – Law(s) Governing the eForm MR-2 Section and Rule […]
(1) This Act may be called the National Institute of Pharmaceutical Education and Research (Amendment) Act, 2021. (2) It shall come into force on such date as the Central Government may, by notification in the Official Gazette, appoint.
A correction has been made in Public Notice 43/2015-20 issued on 16.12.2021 so that MEIS Serial no. 8145 is read as MEIS Serial no. 8147.
eForm Serious Complaints Form- Relating to removal/cessation of Director, Complaint of Serious Nature Fraud, Management Dispute, Financial Irregularities, Accounting Fraud etc. Part I – Overview of Serious Complaint Form A complainant can file a Serious Complaint eForm in the following cases by uploading a Serious Complain eForm available at http://www.mca.gov.in/: Cessation of Director Removal of […]
